Journal article
Editorial Commentary: Adoption of New Medical Technology Requires Replication of Consistent Results Across Multiple Studies: Biologic Injections for Knee Osteoarthritis
Arthroscopy, Vol.39(1), pp.79-81
01/2023
DOI: 10.1016/j.arthro.2022.08.010
PMID: 36543426
Abstract
Determining when to adopt new treatment methods in a clinical practice is a challenging undertaking. Uncertain outcomes of emerging technology can undermine the impartial assessment of risk and benefit. “Optimism bias” can lead to premature adoption of technology. An additional risk is that influential colleagues often persuade clinicians to innovate. “Replicability” or obtaining consistent results across studies aimed at answering the same scientific question must be a goal prior to adoption of innovative devices and treatments. The ability to replicate the results by a separate research group in a similar population with different input data is critical to gaining acceptance from providers without a personal stake in the development of technology.
Details
- Title: Subtitle
- Editorial Commentary: Adoption of New Medical Technology Requires Replication of Consistent Results Across Multiple Studies: Biologic Injections for Knee Osteoarthritis
- Creators
- Joseph W. Galvin - University of Washington Tacoma
- Contributors
- Jason A. Grassbaugh (Editor) - Editorial Board
- Resource Type
- Journal article
- Publication Details
- Arthroscopy, Vol.39(1), pp.79-81
- DOI
- 10.1016/j.arthro.2022.08.010
- PMID
- 36543426
- NLM abbreviation
- Arthroscopy
- ISSN
- 0749-8063
- eISSN
- 1526-3231
- Publisher
- Elsevier Inc
- Grant note
- Madigan Army Medical Center, United States (https://doi.org/10.13039/100010193)
- Language
- English
- Date published
- 01/2023
- Academic Unit
- Orthopedics and Rehabilitation
- Record Identifier
- 9984618648002771
Metrics
6 Record Views